All News

November 20, 2024

Ladder Secures Over $100 Million in New Funding to Scale #1 Strength Training App

November 20, 2024

Aalyria and iSEE Partner to Deliver Best-in-Class Space Traffic Management Solution

November 20, 2024

Booz Allen Strengthens AI Portfolio to Ensure Trust and Protect Citizens

November 19, 2024

TOUCH, The Black Breast Cancer Alliance and Partners Launch the Black TNBC Sanctuary Resource Hub

November 19, 2024

Enlightenment Capital Closes Oversubscribed Fund V at $825 Million

November 19, 2024

AeroVironment to Acquire BlueHalo Establishing Next-Generation Defense Technology Company

November 18, 2024

Chrysalis BioTherapeutics, Inc. Announces Collaboration with NIAID to Evaluate Chrysalin® for the Treatment of Cutaneous Radiation Injury

November 18, 2024

DigitalOwl Announces Strategic Collaboration with ExamOne to Improve Record Retrieval and Analysis

November 18, 2024

Contineum Therapeutics Expands Clinical Development of PIPE-791 With FDA Authorization of Its Investigational New Drug (IND) Application for Chronic Pain

November 15, 2024

Precision BioSciences Highlights Preclinical Data and Outlines Design of First-in-Human Clinical Trial for PBGENE-HBV for Treatment of Chronic Hepatitis B

November 15, 2024

Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases

November 15, 2024

Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal Cancer

Business & Leadership